Category	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	534,612	664,717	727,476	844,583	953,951	1,045,049	1,268,254
Operating Profit	5,837	-2,447	7,713	-47,076	-9,567	-59,684	-48,775
Net Profit	52,368	-34,179	-21,844	-69,659	-5,560	-14,550	-146,708

Balance Sheet (Consolidated)

Unit: Million won

Category	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Total Assets	1,162,923	1,313,710	1,535,125	1,607,008	1,725,570	2,184,761	2,547,575
Total Liabilities	496,625	676,834	742,013	955,072	1,069,236	1,475,529	1,738,327
Total Equity	666,298	636,876	793,112	651,936	656,334	709,231	809,249

CHA Biotech Revenue (Separate)

Unit: 100 million won

CAGR 13%

Income Statement (Separate)

Unit: Million won

Category	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	30,320	26,760	35,288	42,326	69,178	54,009	62,225
Operating Profit	-308	273	-1,757	-879	17,806	-339	-4736
Net Profit	43,798	-7,080	-8,818	-61,893	1,407	52,696	-28,974

Balance Sheet (Separate)

Unit: Million won

Category	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Total Assets	320,193	390,989	398,180	395,402	426,432	704,706	929,274
Total Liabilities	80,913	157,391	87,533	145,880	175,034	401,307	454,165
Total Equity	239,279	233,597	310,647	249,521	251,397	303,399	475,109

CHA Network

[Main Office] CHA Bio Complex, 335 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13488, Korea

Affiliates

Global Healthcare

Business